Thomas Doyle - Jan 29, 2024 Form 4 Insider Report for Kura Oncology, Inc. (KURA)

Role
SVP, Finance & Accounting
Signature
Teresa Bair, Attorney-in-fact for Thomas Doyle
Stock symbol
KURA
Transactions as of
Jan 29, 2024
Transactions value $
-$41,262
Form type
4
Date filed
1/31/2024, 05:30 PM
Previous filing
Jan 4, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KURA Common Stock Sale -$10.6K -594 -1.18% $17.80 49.8K Jan 29, 2024 Direct F1
transaction KURA Common Stock Sale -$13.5K -761 -1.53% $17.80 49.1K Jan 29, 2024 Direct F2
transaction KURA Common Stock Sale -$17.1K -963 -1.96% $17.80 48.1K Jan 29, 2024 Direct F3
holding KURA Common Stock 500 Jan 29, 2024 spouse's 401(k)
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sell-to cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 1/26/22.
F2 Sell-to cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 2/7/22.
F3 Sell-to cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 2/16/23.